title: Compliance to longterm vasoactive intracavernous therapy.
abstract: From December 1986 to December 1991, 107 patients with organic impotence were advised to intracavernous pharmacological therapy with papaverine. Sixteen patients refused such treatment: 91 patients, after the determination of the therapeutical dose, underwent self injection. The follow up was 30-90 months. Thirty-seven patients (40.7%) withdraw the treatment within 3 months: 3 patients (3.3%) after losing the partner; 9 (9.9%) for intercurrent disease; 23 (25.3%) were unsatisfied for the therapy; 2 (2.2%) regained spontaneous erections. Complications were: local haematomas in 23 (42.6%); prolonged erections in 6 (11.1%); fibrotic changes of the corpora cavernosa in 9 patients (16.7%); liver enzymes changes in 2 (3.7%). The reasons for the low compliance to the intracavernous pharmacological therapy with papaverine were analysed.
authors.affiliation: Cattedra e Divisione di Urologia, Università degli Studi di Bari, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Pagliarulo
authors.forename: G M
authors.initials: GM
authors.lastname: Ludovico
authors.forename: E
authors.initials: E
authors.lastname: Cirillo-Marucco
authors.forename: A
authors.initials: A
authors.lastname: Corvasce
authors.forename: G
authors.initials: G
authors.lastname: Pagliarulo
mesh_terms: D000328:Adult; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage* / Q000627:therapeutic use; D010349:Patient Compliance; D010413:Penis; D012189:Retrospective Studies; D012646:Self Administration; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D014665:Vasodilator Agents; D010208:Papaverine